Contracts › 75N94023F00004
75N94023F00004: Bpca Innovative Trial Designs and Assay Developments in Pediatric Therapeutics
Awarded to Duke University by National Institutes of Health (NIH).
$8.8Mobligated
$8.8Mpotential value
27 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N94023F00004 |
|---|---|
| Vehicle | 75N94018D00003 |
| Awardee | Duke University |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | NC |
| Period of performance | 28 September 2023 to 27 September 2027 |
| Potential end | 27 September 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record